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Abstract 
We describe a patient with autism and a paracentric inversion of chromosome 2q14.2q37.3, with a 
concurrent duplication of the proximal breakpoint at 2q14.1q14.2 and a deletion of the distal breakpoint 
at 2q37.3. The abnormality was derived from his mother with a balanced paracentric inversion. The 
inversion in the child appeared to be cytogenetically balanced but subtelomere FISH revealed a cryptic 
deletion at the 2q37.3 breakpoint. High-resolution single nucleotide polymorphism array confirmed the 
presence of a 3.5 Mb deletion that extended to the telomere, and showed a 4.2 Mb duplication at 
2q14.1q14.2. FISH studies using a 2q14.2 probe showed that the duplicated segment was located at the 
telomeric end of chromosome 2q. This recombinant probably resulted from breakage of a dicentric 
chromosome. The child had autism, mental retardation, speech and language delay, hyperactivity, growth 
retardation with growth hormone deficiency, insulin-dependent diabetes, and mild facial dysmorphism. 
Most of these features have been previously described in individuals with simple terminal deletion of 
2q37. Pure duplications of the proximal chromosome 2q are rare and no specific syndrome has been 
defined yet, so the contribution of the 2q14.1q14.2 duplication to the phenotype of the patient is 
unknown. These findings underscore the need to explore apparently balanced chromosomal 
rearrangements inherited from a phenotypically normal parent in subjects with autism and/or 
developmental delay. In addition, they provide further evidence indicating that chromosome 2q terminal 
deletions are among the most frequently reported cytogenetic abnormalities in individuals with autism. 
 
 
Key words: paracentric inversion; 2q37 deletion syndrome; duplication; chromosome 2; autism; mental 
retardation; DNA microarray 
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INTRODUCTION 
Autism is a neurobehavioral syndrome characterized by impairment in social interaction and 
communication and by restricted and repetitive patterns of interests and activities [American Psychiatric 
Association, 1994]. The prevalence of autism spectrum disorders (ASDs) is 0.6% and is four times 
higher in males than in females [Chakrabarti and Fombonne, 2005]. Twin studies, sibling recurrence 
rates, and the association with genetic disorders and chromosomal abnormalities indicate that ASDs have 
a strong genetic component with complex inheritance [Abrahams and Geschwind, 2008]. Linkage and 
association studies have failed to identify any definite susceptibility genes for idiopathic autism. 
Chromosomal abnormalities are detected by routine karyotyping in about 4%-5.8% of individuals with 
idiopathic autism [Veenstra-Vanderweele et al., 2004; Marshall et al., 2008]. Recent studies using higher 
resolution approaches such as comparative genomic hybridization or single nucleotide polymorphism 
(SNP) arrays show that approximately 10% of patients with sporadic ASD have de novo copy number 
variations (CNVs) [Autism Genome Project Consortium, 2007; Sebat et al., 2007; Marshall et al., 2008]. 
A great variety of structural chromosomal abnormalities have been reported for all chromosomes 
[Castermans et al., 2004; Veenstra-Vanderweele et al., 2004; Vorstman et al., 2006]. The occurrence of 
autism or autistic features in children with deletion of the terminal band of chromosome 2q has been 
reported in a growing number of cases [Conrad et al., 1995; Ghaziuddin and Burmeister, 1999; Smith et 
al., 2001; Wolff et al., 2002; Lukusa et al., 2005; Reddy, 2005; Wassink et al., 2005; Sebat et al., 2007; 
Galasso et al., 2008]. In a review of 66 individuals with 2q37 terminal deletion, autism or autistic 
behavior were reported in 24% of patients [Casas et al., 2004]. However, few of the reported 2q37 
deletions have been delineated with precision, precluding the identification of a minimal deleted region 
that might contain one or more genes involved in the autistic phenotype. 
Here we report on a paracentric inversion of chromosome 2q in a boy with autism. The inversion was 
inherited from the healthy mother and appeared to be cytogenetically balanced but fluorescent in situ 
hybridization (FISH) as well as high-resolution SNP microarray revealed a 2q37.3 deletion at the distal 
breakpoint and a 2q14.1q14.2 duplication of the proximal breakpoint of the inversion, with the 
duplicated material located at the distal end of chromosome 2q. We present the phenotypic, cytogenetic, 
and molecular genetic findings in this patient. 
 
MATERIALS AND METHODS 
Subject 
The patient was ascertained as part of a study of genetic and perinatal risk factors in autism, 
performed in an epidemiological cohort of children born between 1985 and 1998 and living in three 
neighboring French counties (Isère, Savoie, and Haute-Savoie). Children were evaluated by a child 
neurologist and a laboratory workup was performed to identify the underlying etiology, including 
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screening for chromosome anomalies, fragile X syndrome and inborn errors of metabolism. The study 
was approved by the local research ethics board. Written informed consent was obtained from all 
families. 
Cytogenetic and Molecular Analyses 
Cytogenetic analysis. Conventional cytogenetic investigations were performed according to standard 
methods on lymphocytes from phytohemaglutinin-stimulated peripheral blood cultures. Chromosome 
spreads were processed for RHG and GTG banding. 
FISH. We performed multi-subtelomeric FISH using a multiprobe system (Cytocell, Oxfordshire, 
UK). Chromosome denaturation, hybridization and signal detection were done according to the 
manufacturer's instructions. Slides were analyzed on a Zeiss epifluorescent microscope equipped with 
appropriate filters and a Metasystems image analysis system was used to analyze the subtelomeric region 
of every chromosome for deletions and balanced translocation events. The p-arm probes were labeled 
with digoxigenin and detected using a fluorescein isothiocyanate (FITC)-conjugated amplification 
system. The q-arm probes were labeled with biotin and detected with Cy3 conjugated antibodies. Cells 
were counterstained with 4,6-diamino-2-phenylindole (DAPI). 
In addition, FISH investigations on chromosome 2 were carried out using a whole chromosome 
painting probe (WCP 2 Oncor, Gaithersburg, MD), a subtelomeric Tel 2q probe (TelVysion probe 2q; 
Vysis, Downers Grove, IL), 10 BAC clones located at 2q37.3 (Table I) and one clone at 2q14.2 (RP11-
77A13). 
Whole-genome SNP array. The patient and both parents were analyzed with the HumanCNV370-
Duo DNA Analysis BeadChip (Illumina, San Diego, CA) containing over 370,000 markers. 
Approximately 750 ng of genomic DNA were used to genotype each sample. Samples were processed 
according to the Infinium II assay manual. Briefly, each sample was whole-genome amplified, 
fragmented, precipitated, and re-suspended in an appropriate hybridization buffer. Denatured samples 
were hybridized on the HumanCNV370-Duo BeadChip for a minimum of 16 h at 48°C. After 
completion of the assay, the BeadChips were scanned with a two-color confocal BeadArray reader. 
Image intensities were extracted and analyzed using Illumina’s BeadStudio 3.0 software. 
Real-time quantitative PCR. Quantitative PCR (qPCR) was used to confirm the deletion and 
duplication identified at the inversion breakpoints. We used the Universal Probe Library (UPL) system 
(Roche, Indianapolis, IN), which consists of a library of 90 fluorescence-labeled probes covering over 
98% of the genome when paired with region-specific primers. Probes were chosen according to the gene 
sequences specified using ProbeFinder v2.04 software (Roche, http://www.universalprobelibrary.com). 
Primers to be used with the UPL probes were also designed with the ProbeFinder application. Ten l 
reactions were assembled with 25 ng DNA, 400 nM of each primer, 100 nM UPL probe (Roche), and 1X 
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Platinum Quantitative PCR SuperMix-Uracil-D-Glycosylase (UDG), with Rox (Invitrogen, Carlsbad, 
CA). All reactions were performed in triplicate. In addition to the DNAs and the genes to be assayed for 
copy number, each 384-well plate included three control samples and three reference genes, as well as a 
no-template control for each gene. PCR conditions were as follows: 2 min UDG activation at 50°C, 2 
min denaturation at 95°C, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min. The plate was 
analyzed with an ABI PRISM 7900HT sequence detection system (Applied Biosystems, Foster City, CA, 
USA). Raw data were obtained with the SDS v2.3 software (Applied Biosystems) and exported for 
analysis with qBase [Hellemans et al., 2007]. 
 
RESULTS 
Clinical Report 
The patient is a Caucasian 14-year-old boy, the second child of non-consanguineous healthy parents. 
The family history was unremarkable. He was born at 39 weeks gestation by vaginal delivery. Birth 
weight was 3350 g (25th-50th centile), birth length 49 cm (50th centile) and head circumference 34 cm 
(10th-50th centile). Apgar scores were 10 and 10 at 1 and 5 min. The mother was 26 years old and the 
father 31 years old at the time of birth. During the first 6 months he was noted to be somewhat 
hypoactive, but his motor milestones were normal; he sat at 9 months and walked at 14 months. The 
parents first realized something was wrong when he was 18 months old: he became hyperkinetic, often 
banging his head against the wall, did not answer to his name and avoided eye contact. He was fascinated 
with electrical sockets, the first thing he would explore when he arrived in a new place. Speech and 
language development were delayed; he started to use meaningful words at 30 months and phrases at 60 
months. His non-verbal communication was also delayed: he did not point and his range of facial 
expressions was limited. He started nursery school at the age of 3 years and had difficulty integrating. He 
was evaluated at that time by a psychiatrist who prescribed a neuroleptic as a sedative. By the age of 5 he 
would not show or share things he liked, was aloof, seldom interacting with peers, and had no 
imaginative play. He had overall speech delay with occasional pronoun reversal and particularities, 
including excessive questioning and preoccupation with particular topics. He was constantly active and 
sometimes agitated for no reason. He received speech and occupational therapy and when he was 9 he 
started to attend a specialized medical institution for children with autism. 
At the time of evaluation at the age of 12 years he had made progress in the domains of social 
interaction and language. Despite some attempts to communicate with others, he was often rejected by 
other children. He still lacked social reciprocity and was excessively interested in all things electronic. 
He had been less active since he had started taking Ritalin 2 years before, but its effect tended to decrease 
and he became more anxious. During the examination he was anxious; he showed no social withdrawal 
but exhibited poor eye contact. His voice was loud and monotonous and he had a poor range of facial 
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expressions. His activity level was generally low with occasional outbursts of increased activity and his 
gestures were clumsy. 
Based on his medical history and the above examination, he meets DSM-IV criteria for autistic 
disorder [American Psychiatric Association, 1994], because of the combination of deficits in reciprocal 
social interactions and language, and ritualistic interests. On the Childhood Autism Rating Scale (CARS) 
his score was 30.5, indicating mild-moderate autism. On the Autism Diagnostic Interview-Revised (ADI-
R) he met all the cut-offs for autistic disorder [Lord et al., 1994]. The global IQ, evaluated with the 
Wechsler Intelligence Scale for Children–III, was 46. Verbal IQ and performance IQ were 46 and 50, 
respectively. 
The patient has a personal history of asthma, insulin-dependent diabetes, and growth retardation with 
growth hormone deficiency. He is treated with an association of corticoids, beta2 agonist, insulin and 
growth hormone. There was no history of seizures. An electroencephalogram and brain MRI performed 
at the age of 3 found no abnormalities. On physical examination at 12 years, he had short stature (142 
cm, 14th centile), with normal weight (40 kg) and head circumference (54 cm). No pubertal development 
was observed. He had mild facial dysmorphism with frontal bossing, flattened nasal bridge, deep set 
eyes, down-slanting palpebral fissures, and thin upper lip (Fig. 1). 
Except for the karyotype (see below), other laboratory investigations performed at the time of 
evaluation were normal, including FISH for 15q11-q13, 22q11.2 and 22q13, fragile X molecular testing 
and metabolic screening for inborn errors of metabolism. A new brain MRI was within normal limits. 
Cytogenetic and Molecular Analyses 
RHG-banding and GTG-banding analysis in the patient showed a large paracentric inversion on the 
long arm of chromosome 2, inv(2)(q14.2q37.3) (Fig. 2A). This chromosomal abnormality appeared to be 
balanced and was inherited from the phenotypically normal mother. However, FISH studies with 
subtelomeric probes in the patient showed a deletion of the Cytocell 2q probe DJ1011O17 (Fig. 2B), 
which includes markers 2QTEL86 (D2S2987), 2QTEL37 (D2S2985), 2QTEL47 (D2S2986) and 
2QTEL44 (D2S2585). Because polymorphisms resulting from the variable length of the target sequence 
have been reported with clone D2S2986 [Knight and Flint, 2000], we used two other probes, 172113 
(D2S447; Cytocell) and the TelVysion 2q probe VIJyRM2112 (D2S447; Vysis), to analyze the 
subtelomeric 2q region. These non-polymorphic probes were also deleted (Fig. 2C), indicating that the 
patient has a submicroscopic deletion of the 2q37.3 region. No 2q terminal deletion was observed in the 
mother. 
To further delineate the distal breakpoint in the patient, 10 BACs of the 2q37 region were used. The 
results are shown in Table I. The BAC clone immediately proximal to the deletion was RP11-320G1, 
while no hybridization was seen for clones RP11-162P12 and RP11-546M8. According to these results, 
the distal breakpoint is on 2q37.3.  
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High-resolution SNP microarray in the patient confirmed the presence of a 3.5 Mb deletion at the 
distal breakpoint of the inversion on the maternally derived chromosome, extending to the telomere 
(chr2:239,400,015–tel, hg18) (Fig. 3). The microarray also revealed a 4.2 Mb duplication at the proximal 
breakpoint, at 2q14.1q14.2 (116,789,226–121,021,018) (Fig. 3). Both parents had normal profiles. The 
technique did not find any other potentially significant CNVs. The results of the SNP array were 
confirmed by real-time qPCR. Figure 4 shows duplication of genes EN1 and MARCO located at 2q14.2 
as well as deletion of OTOS, C2orf54, and HDLBP located at 2q37.3, with normal dosage of the genes 
flanking the rearranged regions. 
FISH with BAC clone RP11-77A13 (2q14.2) confirmed the duplication in the patient, and showed 
that the duplicated material was telomeric, distal to the inverted region (Fig. 5A). In the mother, clone 
RP11-77A13 hybridized to the expected region on both chromosomes 2 (Fig. 5B and C), indicating that 
the proximal breakpoint of the inversion was located distally. RP11-475A20 (2q37.3) was inverted and 
hybridized very closely but distal to RP11-77A13 (2q14.2) (Fig. 5B), whereas RP11-546M8 (2q37.3), 
previously shown to be deleted in the patient, was not deleted in the mother and hybridized to the 
telomeric region (Fig. 5C). This locates the proximal breakpoint of the paracentric inversion in 2q14.2, 
just distal to BAC RP11-77A13. From these analyses, the abnormal karyotype in the patient is: 
46,XY,rec(2)inv(2)(q14.2q37.3)mat.ish rec(2)del(2)(q37.3qter)(wcp2+,RP11-162P12–,qter–
)dup(2)(q14.2)(RP11-77A13++)dn. 
 
DISCUSSION 
Paracentric inversions are intrachromosomal rearrangements that result from a two break event 
occurring on the same chromosome arm, followed by the insertion of the intercalary segment after a 180° 
rotation. Because they do not alter chromosome arm ratios, paracentric inversions can remain undetected. 
In addition, they are usually not associated with an abnormal phenotype. For these reasons, the incidence 
of paracentric inversions has not been clearly established; estimations range from 0.09/1000 to 0.49/1000 
[Pettenati et al., 1995]. Paracentric inversions of nearly all chromosomes have been reported [Madan, 
1995], with most being inherited [Fryns et al., 1986; Madan, 1995; Pettenati et al., 1995]. A high 
incidence of mental retardation (26%) and congenital malformations has been reported in the inversion 
carrier offspring of phenotypically normal parents with apparently identical chromosomal 
rearrangements [Fryns et al., 1986]. These findings could be explained by the non detection of a small 
chromosomal imbalance [Fryns et al., 1986]. In a review of 446 paracentric inversions, there were 15 
cases of recombinant chromosomes with duplication and/or deletion [Pettenati et al., 1995]. With the 
higher resolution techniques available today, this figure would likely be much higher. According to 
classic genetic mechanisms, a crossover in a paracentric inversion loop produces dicentric chromosomes 
and acentric fragments with deletions and duplications. The instability of these chromosome structures 
reduces the frequency of viable recombinants. Alternative mechanisms have been proposed to explain 
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unabalanced products in liveborn children, including breakage of a dicentric bridge, unequal crossover, 
or U-type exchange within the inversion loop [reviewed in Madan and Nieuwint, 2002]. Others have 
suggested that the paracentric inversions may be in fact insertions, which carry a high risk of 
recombination products [Madan and Nieuwint, 2002].  
In our patient, the paracentric inversion of 2q14.2q37.3 was inherited from the mother. At a standard 
cytogenetic level, the inversion was identical in the patient and his mother. However, FISH and SNP 
array analysis revealed the occurrence of a 3.5 Mb deletion at the distal breakpoint (2q37.3) extending to 
the telomere and a 4.2 Mb duplication at the proximal breakpoint (2q14.1q14.2) only in the patient (Fig. 
6). FISH studies in the mother confirmed the presence of a paracentric inversion, and excluded the 
possibility of an inverted intrachromosomal insertion. The imbalances in the child are most likely the 
result of crossover in the inversion loop of chromosome 2 during maternal meiosis. We hypothesize that 
during the first meiotic division, a crossover occurred in the inverted chromosome near the proximal 
breakpoint (between 2q14.2 and 2q37.3), leading to the formation of a dicentric chromosome (Fig. 7). 
During anaphase, the dicentric chromosome formed an anaphase bridge that broke when the centromeres 
joined the opposite pole. The break occurred between the centromeric region and 2q14.2. Thus, the result 
is the inverted chromosome with a terminal deletion and a duplicated region distal to the inversion. A 
similar mechanism was suggested for a duplication-deficiency monocentric chromosome 18 resulting 
from a maternal paracentric inversion [Courtens et al., 1998]. Based on these observations, we suggest 
that genetic counseling and prenatal diagnosis should be offered to couples where one of the members is 
a carrier of a paracentric inversion. In the case of inversion carrier offspring, molecular cytogenetic 
analysis should complete the standard karyotype. 
To date, about 100 patients with terminal deletions with breakpoints at 2q37 have been reported [Falk 
and Casas, 2007]. The most commonly reported features include developmental delay/mental retardation, 
abnormal behavior including autism or autistic features, hypotonia, mild facial dysmorphism (frontal 
bossing, round face, depressed nasal bridge, abnormal or prominent ears, deep-set eyes, anteverted nares 
and thin upper lip), short stature, and short hands or feet [Conrad et al., 1995; Ghaziuddin and 
Burmeister, 1999; Aldred et al., 2004; Casas et al., 2004]. Albright hereditary osteodystrophy-like 
brachymetaphalangia has been reported in approximately 50% of patients [Aldred et al., 2004; Casas et 
al., 2004]. Major malformations are observed in a third of patients with 2q37 monosomy, and include 
cardiac, gastrointestinal, renal, genitourinary and central nervous system malformations. A phenotype-
breakpoint correlation based on 66 individuals with chromosome 2q terminal deletion showed that 
malformed kidneys and structural brain anomalies were limited to patients with the largest deletions, 
with breakpoints at or proximal to 2q37.1 [Casas et al., 2004]. However, attempts to define the minimal 
deleted regions for the major features of the syndrome have been rendered difficult by the considerable 
clinical variability apparent even among patients with similar breakpoints [Aldred et al., 2004]. 
Furthermore, most of the reported cases with 2q terminal deletions have not been characterized 
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molecularly with FISH and high-resolution microarray analysis, so the size of the deletion, the precise 
breakpoints and the possible presence of other cryptic genomic rearrangements has not been determined. 
Such studies are essential to establish genotype-phenotype correlations and to provide prognostic 
information and genetic counseling to parents. 
The phenotype of our patient is similar to that described in other individuals with terminal 2q 
deletions, including mental retardation, autism, and characteristic facial appearance. He did not have 
brachymetaphalangia or major malformations, although the former maybe difficult to recognize in some 
preadolescent subjects. His case was complicated by insulin-dependent diabetes mellitus and 
hyposecretion of growth hormone. Although growth hormone deficiency has been described in 
association with 2q37 deletions [Kitsiou-Tzeli et al., 2007], diabetes has not been associated with the 
2q37 deletion syndrome, so it might be either a rare manifestation or a coincidental finding. 
Alternatively, the concurrent duplication of 2q14.1q14.2 could play a role in these endocrinopathies. 
Autism or autistic features have been repeatedly described in subjects with 2q37 deletions [Conrad et 
al., 1995; Ghaziuddin and Burmeister, 1999; Smith et al., 2001; Wolff et al., 2002; Lukusa et al., 2005; 
Reddy, 2005; Wassink et al., 2005; Sebat et al., 2007; Galasso et al., 2008]. Among 66 subjects with 
2qter deletion, autistic behavior was observed in 24% [Casas et al., 2004]. However, the prevalence of 
ASDs in terminal 2q deletions is unknown, because most patients have not been assessed formally. The 
Autism Chromosome Rearrangement Database (http://projects.tcag.ca/autism/) lists 35 patients with 
chromosome 2q terminal deletions. Furthermore, in a study of 165 unrelated subjects with autism, Sebat 
et al. [2007] found two with de novo 2q37 deletions. Thus, such deletions are among the most frequent 
cytogenetic abnormalities reported in patients with autism. By comparing the deletion breakpoints of 
three patients with autism carrying terminal 2q37 deletions to those of two siblings without autism, 
Lukusa et al. [2005] suggested that the critical region for autistic disorder appeared to be 1.2 Mb and lied 
between clones RP11-680O16 (236.2 Mb) and RP11-346I14 (237.6 Mb). The deletion breakpoint of our 
patient with autism lies distal to the candidate region, between RP11-320G1 (239.5 Mb) and RP11-
162P12 (239.8 Mb), and therefore does not support the critical region for autism proposed by Lukusa et 
al.  
Telomeric rearrangements play an important role in the etiology of mental retardation, accounting for 
~2.5% of cases [Ravnan et al., 2006]. In a pilot study of 10 patients with autism, one patient with a 
telomeric 2q37.3 deletion was found [Wolff et al., 2002]. However, subsequent studies have shown that 
subtelomeric deletions are rare in patients with non-syndromic ASD [Battaglia and Bonaglia, 2006; Di 
Bella et al., 2006; Wassink et al., 2007]. 
The distal 2q37 deletion in our patient removes 42 genes (Fig. 6). Several genes have been proposed 
as candidates for various aspects of the phenotype, including glypican 1 (GPC1), G-protein-coupled 
receptor 35 (GPR35), serine/threonine protein kinase 25 (STK25), and programmed cell death 1 
precursor (PDCD1). In the context of autism, KIF1A, a member of the kinesin family involved in axonal 
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transport of synaptic vesicles, and FARP2, a Rho GTPase involved in neurite growth and axonal 
guidance, appear as good candidate genes. FARP2, together with HDLBP and PASK, were recently 
shown to be down-regulated in a patient with autism and 2q37.3 deletion syndrome [Felder et al., 2009]. 
It is not known at present whether the 2q37 deletion phenotype represents a contiguous gene deletion 
syndrome or if certain key clinical features result from happloinsufficiency of a single gene. 
The microduplication at 2q14.1q14.2 encompasses 19 genes (Fig. 6). Pure duplications of the 
proximal long arm of chromosome 2 are rare, with only 11 patients reported thus far [Ounap et al., 
2005]. The size of the duplications and the clinical signs are variable and no specific 2q duplication 
syndrome has emerged. No other duplications limited to the 2q14.1q14.2 segment have been reported, so 
the contribution of this genomic imbalance to the patient's phenotype is not known. However, a recent 
analysis of CNVs in the general population reported two apparently normal individuals with duplications 
in 2q14.2 (one encompassing EN1, MARCO, C1QL2, and STEAP3, chr2:119,295,788-119,743,129, and 
the other encompassing MARCO, C1QL2, STEAP3, C2orf76, DB1, TMEM37, and SCTR, 
chr2:119,426,630-119,988,013) [Itsara et al., 2009]. The duplication found in both normal individuals is 
encompassed within the duplicated interval in our patient, suggesting that these genes probably do not 
contribute to his phenotype. 
In conclusion, our data provide further evidence indicating that chromosome 2q terminal deletions are 
among the most frequently reported chromosomal aberrations in patients with autism and suggest that 
haploinsufficiency of one or more genes deleted within a 3.5 Mb segment of the 2q37.3 region may 
predispose to autism. Furthermore, these findings suggest that the molecular study of apparently 
“balanced” chromosomal rearrangements inherited from a phenotypically normal parent is warranted in 
patients with autism and/or developmental delay. 
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Table I. Clones spanning the 2q37.3 region used in FISH experiments in the patient 
 Clone Location (Mb) FISH signal 
RP11-488K22 238.19 inverted 
RP11-526L8 238.66 inverted 
RP11-40B20 238.95 inverted 
RP11-225M4 239.07 inverted 
RP11-475A20 239.27 inverted 
RP11-55A23 239.31 inverted 
RP11-136O17 239.34 inverted 
RP11-320G1 239.52 inverted 
RP11-162P12 239.76 deleted 
RP11-546M8 239.98 deleted 
DJ1011O17 242.50 deleted 
VIJyRM2112 (D2S447) 242.53 deleted 
NP 172113 (D2S447) 242.53 deleted 
 
 
 
 
 
 
Fig. 1. Photo of the patient. Note mild dysmorphic features, with frontal bossing, flattened nasal bridge, deep set 
eyes, down-slanting palpebral fissures, and thin upper lip.  
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Fig. 2. a. Partial G-banding karyotype of chromosome 2 in the patient showing the paracentric inversion (q14.2-
q37.3). The inverted segment is indicated by arrows. b,c. FISH analysis with chromosome 2 subtelomeric probes 
(Chromoprobe Multiprobe System, Cytocell). On the normal chromosome 2, the p and q subtelomeres are labeled 
green and red, respectively. Both probe DJ1011O17 (b) and the non-polymorphic probe 172113 (D2S447) (c) show 
a telomeric deletion of the long arm, indicated by arrows. 
 
 
 
 
Fig. 3. SNP array results of chromosome 2 in the patient and his parents. SNP array ratio profiles of 
chromosome 2 showing chromosomal imbalances in the patient and normal profiles in the parents. The duplicated 
(2q14.1q14.2) and deleted (2q37.3) intervals in the patient are indicated by green and red arrows, respectively. The 
X axis indicates the chromosomal position (Mb) and the Y axis shows the intensity ratio represented on a log 2 
scale. Individual SNPs are represented as blue dots and the average Log ratio is shown as a red line; a ratio of 0 
indicates the presence of 2 alleles and is considered normal. 
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Fig. 4. qPCR gene dosage of duplicated and deleted regions. qPCR was used to confirm the duplication 
(2q14.1q14.2) and deletion (2q37.3) in the patient. Genes within the deleted or duplicated intervals and the flanking 
regions were targeted with qPCR probes in the patient and two controls. Data represent mean+SEM. A gene dosage 
ratio of 1 indicates the presence of 2 alleles and is considered normal; values above correspond to a duplication and 
values below indicate a deletion.  
 
 
 
 
Fig. 5. a. FISH analysis with clone RP11-77A13 (2q14.2, red) and a centromeric probe (green) in the patient 
showed that the duplicated 2q14.2 material was located at the telomeric end of chromosome 2q. b,c. FISH analysis 
with clone RP11-77A13 (2q14.2, red) in the mother shows normal hybridization to both chromosomes 2, indicating 
that the proximal breakpoint of the inversion was located distally. Clone RP11-475A20 (2q37.3) was inverted and 
hybridized very close to RP11-77A13 (2q14.2) on one of the homologues (b), whereas clone RP11-546M8, which 
hybridizes to the 2q telomeric region, showed normal signals (c). 
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Fig. 6. Schematic representation of chromosome 2 rearrangements in the patient. The duplicated 
(2q14.1q14.2) and deleted (2q37.3) intervals are surrounded by green and red rectangles, respectively, on the 
ideogram; close-ups of both regions including the chromosomal position and gene content are depicted above and 
below, respectively. The inverted region is indicated by a blue bar. Deleted FISH probes are shown in red, 
duplicated probes in green. The additional copy of the 2q14.2 segment was shown by FISH to be located near the 
2q telomere. 
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Fig. 7. Breakage of a dicentric chromosome as a mechanism for the formation of the recombinant observed 
in the patient. Letters A-F correspond to the chromosomal regions indicated at the top: C and E are within the 
inversion, while B and F flank the inversion. a. One of the two maternal chromosomes carries a paracentric 
inversion of 2q. b. During meiosis I, the inverted chromosome forms a loop; crossover between nonsister 
chromatids within the loop results in abnormal chromosome structures. c. As the chromosomes separate to opposite 
poles, a dicentric chromosome and an acentric fragment are formed. The acentric fragment is lost, while the 
dicentric bridge is pulled in opposite directions and breaks. d. Meiosis II generates a normal chromosome, a deleted 
chromosome, an inverted chromosome carrying a deletion distal to the inversion and a proximal duplication, with 
the duplicated segment located at the telomeric end, and an inverted chromosome. The recombinant transmitted to 
the patient is indicated by an asterisk.  
